Researchers at the University of California, Davis have developed a framework that enables autonomous systems to plan paths while accounting for how their actions influence surrounding actors. Unlike existing approaches that rely on reactive planning with fixed predictions or on computationally intensive multi-agent formulations, this technology uses a structured, data-driven interaction model within a tractable theoretical framework. The approach is designed for real-time deployment and supports analyzable performance and safety behavior under defined conditions. It enables more adaptive navigation in environments shared with people or other intelligent machines, improving operational efficiency, safety margins, and integration potential across a range of autonomous products.

Researchers at the University of California, Davis have developed a system and method to continuously separate granular material mixtures based on differences in their frictional properties using non-antiperiodic vibratory excitation.

Researchers at the University of California, Davis have developed a modular CRISPR activation platform that enables precise upregulation of the haploinsufficient gene FOXG1 to address neurodevelopmental disorders without DNA cleavage.

Researchers at the University of California, Davis have developed a modular, containerized cooling solution designed to support high‑density computing environments such as data centers and AI clusters. The system combines efficient air‑to‑liquid heat exchange, integrated energy storage options, and intelligent controls to reduce operating costs, improve deployment speed, and enhance system uptime.

Researchers at the University of California, Davis have developed an advanced system that decodes semantic content directly from neural signals to enable natural language communication for users with speech impairments.

Researchers at the University of California, Davis have developed ibogaine-related compounds that promote neural plasticity and treat neuropsychiatric and neurological disorders.

Researchers at the University of California, Davis have developed non-hallucinogenic compounds with clinically relevant therapeutic efficacy that promote neural growth and plasticity.

Researchers at the University of California, Davis have developed a class of compounds intended for the treatment of neurodegenerative diseases such as Alzheimer's by inhibiting DYRK1A kinase and modulating 5-HT2Rs.